Skip to content
Riskpilot
← Back to search
Sign in
Get full access
1stDrugResearch ApS
APS
Dissolved
Advertising protection
CVR 40927697
Bytoften 2E, 8660
Skanderborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
1stDrugResearch ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
Income statement
DKK thousands
Item
2019
2020
Gross profit
99
-11
Staff expenses
-0
-0
EBITDA
99
-11
Depreciation & amort.
-0
-0
EBIT
99
-11
Net financials
0
-1
Profit before tax
99
-13
Tax
23
-2
Net profit
76
-10
Balance sheet
DKK thousands
Item
2019
2020
Total assets
204
143
Equity
116
106
Long-term debt
0
0
Short-term debt
88
37
Total debt
88
37
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1147500.0%
This company
2019
2020
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
2019
2020
Return on equity
-9.9%
This company
18.4%
Market median
-154% vs market
2019
2020
Net profit margin (of gross profit)
-1041300.0%
This company
2019
2020
Asset turnover (of gross profit)
-0.08×
This company
2019
2020
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2019
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-11-07 – 2019-12-31
View
PDF
More on 1stDrugResearch ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
